Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan · Delayed Price · Currency is TWD 26.65
-0.05 (-0.19%)
Jan 22, 2026, 1:00 PM CST
Orient Pharma Market Cap
Orient Pharma has a market cap or net worth of 6.49 billion as of January 21, 2026. Its market cap has decreased by -20.62% in one year.
Market Cap
6.49B
Enterprise Value
6.14B
Revenue
1.28B
Ranking
n/a
PE Ratio
47.02
Stock Price
26.65
Market Cap Chart
Since June 15, 2012, Orient Pharma's market cap has increased from 4.12B to 6.49B, an increase of 57.65%. That is a compound annual growth rate of 3.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 6.49B | 2.10% |
| Dec 31, 2025 | 6.36B | -20.85% |
| Dec 31, 2024 | 8.03B | 80.00% |
| Dec 29, 2023 | 4.46B | 14.13% |
| Dec 30, 2022 | 3.91B | 11.76% |
| Dec 30, 2021 | 3.50B | 28.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 254.20B |
| PharmaEssentia | 213.40B |
| Lotus Pharmaceutical | 84.02B |
| Heron Neutron Medical | 69.56B |
| Bora Pharmaceuticals Co., LTD. | 65.48B |
| Oneness Biotech | 33.97B |
| Lumosa Therapeutics | 31.25B |
| Center Laboratories | 31.09B |